Brokers bullish on Gokaldas Exports, Glenmark Pharma

Published on Mon, Aug 07, 2006 at 08:55 |  Source : Moneycontrol.com

Updated at Mon, Aug 07, 2006 at 09:22  

2284 Investors following Esab India. Share this News with them.
0
0
Share on Tumblr

IL&FS Investsmart has kept buy rating on Gokaldas Exports and Glenmark Pharma

Edelweiss has kept buy rating on SpiceJet

ASK RJ has upgraded Patni Comp to hold rating from sell

CLSA has kept underperformer rating on TCS; with a target of Rs 880

India Infoline has mainatined buy rating on Divis Lab; with a target of Rs 2,012

Sharekhan has maintained buy rating on Marksans Pharma; with a target of Rs 360

Sharekhan has maintained buy rating on Selan Exporation; with a target of Rs 94

Sharekhan has maintained buy rating on Esab India; with a target of Rs 575

Sharekhan has maintained buy rating on JM Financial; with a target of Rs 720

First Global has kept market performer rating on Tata Steel

ICICI Securities has maintained buy rating on Nestle India and Adlabs

ICICI Securities has maintained buy rating on Ranbaxy

Karvy has maintained buy rating on Omax Auto; with a target of Rs 140

Karvy has maintained buy rating on Avantel Software; with a target of Rs 85

Karvy has maintained buy rating on Liberty Shoes; with a target of Rs 280

Brics Securities has kept buy rating on NTPC; with a target of Rs 139

House

Stocks

Views

IL&FS Investsmart

Gokaldas Exports and Glenmark Pharma

Buy

Edelweiss

SpiceJet

Buy

ASK RJ

Patni Comp

Hold

CLSA

TCS

Underperformer; with a target of Rs 880

India Infoline

Divis Lab

Buy; with a target of Rs 2,012

Sharekhan

Marksans Pharma

 

Selan Exporation

 

Esab India

 

JM Financial

Buy; with a target of Rs 360

 

Buy; with a target of Rs 94

 

Buy; with a target of Rs 575

 

Buy; with a target of Rs 720

First Global

Tata Steel

Market performer

ICICI Securities

Nestle India, Adlabs and Ranbaxy

Buy

Karvy

OmaxAuto

 

Avantel Software

 

Liberty Shoes

Buy; with a target of Rs 140

 

Buy; with a target of Rs 85

 

Buy; with a target of Rs 280

Brics Securities

NTPC

Buy; with a target of Rs 139

 

  

Trending News

Business News

All you need to know about the Google Nexus Tablet
Ambani Mauritius Funds end up with mysterious UBS Customer A "Ambani Mauritius Funds end up with mysterious UBS Customer A"

Mamata, Shah Rukh party; KKR players left out

Tata Motors Says Cash & Equivalents At `25,730 Cr As On March 31

The latest earning numbers FIRST on CNBC-TV18
Videos

May 29 2012, 12:19

Expect Tata Motors Q4 PAT at Rs 4200 cr: StanChart

- in Brokerage Results Estimates

Interviews

May 29 2012, 15:44 | Source: CNBC-TV18

Improving priority sector lending norms main focus: IDBI  

May 29 2012, 13:17 | Source: CNBC-TV18

See net interest margin at 3.6-3.7% in FY13: Federal Bank  

Subscribe to

Moneycontrol Newsletters

Moneycontrol.com offers you a choice of various sectoral and other newsletters for FREE!